Home » Topics » BioWorld Science

BioWorld Science
RSS

Urinary TIMP2 and IGFBP7 as early biomarkers to predict drug induced AKI

Nov. 14, 2019

First-in-human data for ASN-007 presented

Nov. 14, 2019

First patient dosed in phase I/II study of the bicycle toxin conjugate BT-5528

Nov. 14, 2019

Results from multiple phase III studies of anemia treatment roxadustat presented

Nov. 14, 2019

Mouse-human chimeric anti-CXADR antibody shows antitumor activity in prostate and SCLC models

Nov. 14, 2019

First-in-class fusion inhibitor against diverse and multidrug-resistant HCV strains presented

Nov. 14, 2019

SHR-4640: a potential new hyperuricemia treatment option

Nov. 14, 2019

Diabetes drug eases nicotine withdrawal

Nov. 14, 2019

TFEB initiates fat cell browning

Nov. 14, 2019

Bellerophon reports initial data from acute hemodynamic study of INOpulse

Nov. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...